These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1085 related items for PubMed ID: 30142427

  • 1. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW, Wong GL, Chan RS, Shu SS, Cheung BH, Li LS, Chim AM, Chan CK, Leung JK, Chu WC, Woo J, Chan HL.
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [Abstract] [Full Text] [Related]

  • 2. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW, Chan RS, Wong GL, Cheung BH, Chu WC, Yeung DK, Chim AM, Lai JW, Li LS, Sea MM, Chan FK, Sung JJ, Woo J, Chan HL.
    J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
    Mazzotti A, Caletti MT, Brodosi L, Di Domizio S, Forchielli ML, Petta S, Bugianesi E, Bianchi G, Marchesini G.
    J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
    Lim SL, Johal J, Ong KW, Han CY, Chan YH, Lee YM, Loo WM.
    JMIR Mhealth Uhealth; 2020 Apr 13; 8(4):e14802. PubMed ID: 32281943
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease.
    Khoo J, Hsiang JC, Taneja R, Koo SH, Soon GH, Kam CJ, Law NM, Ang TL.
    Liver Int; 2019 May 13; 39(5):941-949. PubMed ID: 30721572
    [Abstract] [Full Text] [Related]

  • 8. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China.
    Liu Z, Jin P, Liu Y, Zhang Z, Wu X, Weng M, Cao S, Wang Y, Zeng C, Yang R, Liu C, Sun P, Tian C, Li N, Zeng Q.
    Nutr J; 2024 Jun 13; 23(1):64. PubMed ID: 38872173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study.
    Zhang HJ, Pan LL, Ma ZM, Chen Z, Huang ZF, Sun Q, Lu Y, Han CK, Lin MZ, Li XJ, Yang SY, Li XY.
    Diabetes Obes Metab; 2017 Feb 13; 19(2):284-289. PubMed ID: 27761987
    [Abstract] [Full Text] [Related]

  • 11. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S, Christiansen S, Nagel J, Wimmer R, Artmann R, Denk G, Bischoff M, Bischoff G, Rust C.
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep 01; 315(3):G329-G338. PubMed ID: 29878845
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
    Li C, Guo P, Okekunle AP, Ji X, Huang M, Qi J, Jiang Y, Feng R, Li R.
    J Gastroenterol Hepatol; 2019 Jan 01; 34(1):256-262. PubMed ID: 29949199
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL, de Piano A, Campos RM, Carnier J, de Mello MT, Elias N, Fonseca FA, Masquio DC, da Silva PL, Corgosinho FC, Tock L, Oyama LM, Tufik S, Dâmaso AR.
    J Clin Lipidol; 2014 Jan 01; 8(3):265-72. PubMed ID: 24793347
    [Abstract] [Full Text] [Related]

  • 18. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
    Koot BG, van der Baan-Slootweg OH, Tamminga-Smeulders CL, Rijcken TH, Korevaar JC, van Aalderen WM, Jansen PL, Benninga MA.
    Arch Dis Child; 2011 Jul 01; 96(7):669-74. PubMed ID: 21518734
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.